Choksi Laboratories [CHOKSILA] vs Syngene [SYNGENE] Detailed Stock Comparison

Choksi Laboratories

BSE
Loading...

Syngene

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Choksi Laboratories wins in 7 metrics, Syngene wins in 12 metrics, with 0 ties. Syngene appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricChoksi LaboratoriesSyngeneBetter
P/E Ratio (TTM)84.1150.13Syngene
Price-to-Book Ratio5.325.36Choksi Laboratories
Debt-to-Equity Ratio123.5212.23Syngene
PEG Ratio-10.093.51Choksi Laboratories
EV/EBITDA13.4724.12Choksi Laboratories
Profit Margin (TTM)3.52%13.61%Syngene
Operating Margin (TTM)10.90%11.44%Syngene
EBITDA Margin (TTM)10.90%11.44%Syngene
Return on Equity6.45%10.50%Syngene
Return on Assets (TTM)2.33%7.30%Syngene
Free Cash Flow (TTM)$40.91M$3.98BSyngene
Dividend YieldN/A0.39%N/A
1-Year Return156.84%-27.89%Choksi Laboratories
Price-to-Sales Ratio (TTM)2.966.80Choksi Laboratories
Enterprise Value$1.55B$246.89BSyngene
EV/Revenue Ratio3.666.62Choksi Laboratories
Gross Profit Margin (TTM)82.45%75.12%Choksi Laboratories
Revenue per Share (TTM)$61$93Syngene
Earnings per Share (Diluted)$2.14$12.58Syngene
Beta (Stock Volatility)0.080.04Syngene
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Choksi Laboratories vs Syngene Stock Performance Analysis

Loading Price Chart...

Choksi Laboratories
Syngene
Choksi Laboratories Stock Overview | Syngene Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Choksi Laboratories4.25%-8.02%-20.17%-3.34%56.24%95.99%
Syngene-0.28%3.29%-2.31%-0.12%-8.98%-27.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Choksi Laboratories156.84%352.69%1,519.72%1,273.93%908.86%301.25%
Syngene-27.89%15.20%14.34%248.49%296.51%296.51%

News Based Sentiment: Choksi Laboratories vs Syngene

Choksi Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Choksi Laboratories, with a share price decline following the AGM offsetting positive long-term returns and a commitment to shareholder communication. The reduced trading volume suggests growing investor caution, making it a moderately significant month for investors.

View Choksi Laboratories News Sentiment Analysis

Syngene

News based Sentiment: MIXED

Syngene International reported positive Q1 FY26 results and is actively expanding its facilities, but faces mixed analyst sentiment and a shifting technical trend. This combination of growth initiatives and cautionary signals creates a complex investment picture, making this a significant month for the company.

View Syngene News Sentiment Analysis

Performance & Financial Health Analysis: Choksi Laboratories vs Syngene

MetricCHOKSILASYNGENE
Market Information
Market Cap i₹1.26B₹254.88B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i8,255420,859
90 Day Avg. Volume i7,354596,172
Last Close₹184.05₹632.70
52 Week Range₹60.21 - ₹236.70₹599.55 - ₹960.60
% from 52W High-22.24%-34.13%
All-Time High₹236.70 (Aug 20, 2025)₹960.60 (Dec 02, 2024)
% from All-Time High-22.24%-34.13%
Growth Metrics
Quarterly Revenue Growth0.05%0.11%
Quarterly Earnings Growth-0.09%0.15%
Financial Health
Profit Margin (TTM) i0.04%0.14%
Operating Margin (TTM) i0.11%0.11%
Return on Equity (TTM) i0.06%0.11%
Debt to Equity (MRQ) i123.5212.23
Cash & Liquidity
Book Value per Share (MRQ)₹33.82₹117.59
Cash per Share (MRQ)₹0.88₹34.82
Operating Cash Flow (TTM) i₹51.38M₹5.00B
Levered Free Cash Flow (TTM) i₹15.23M₹4.96B
Dividends
Last 12-Month Dividend Yield iN/A0.39%
Last 12-Month Dividend iN/A₹2.50

Valuation & Enterprise Metrics Analysis: Choksi Laboratories vs Syngene

MetricCHOKSILASYNGENE
Price Ratios
P/E Ratio (TTM) i84.1150.13
Forward P/E iN/A37.42
PEG Ratio i-10.093.51
Price to Sales (TTM) i2.966.80
Price to Book (MRQ) i5.325.36
Market Capitalization
Market Capitalization i₹1.26B₹254.88B
Enterprise Value i₹1.55B₹246.89B
Enterprise Value Metrics
Enterprise to Revenue i3.666.62
Enterprise to EBITDA i13.4724.12
Risk & Other Metrics
Beta i0.080.04
Book Value per Share (MRQ) i₹33.82₹117.59

Financial Statements Comparison: Choksi Laboratories vs Syngene

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CHOKSILASYNGENE
Revenue/Sales i₹112.42M₹8.75B
Cost of Goods Sold i₹19.73M₹2.18B
Gross Profit i₹92.69M₹6.57B
Research & Development iN/AN/A
Operating Income (EBIT) i₹12.28M₹1.00B
EBITDA i₹29.04M₹2.24B
Pre-Tax Income i₹6.27M₹1.01B
Income Tax i₹2.42M₹146.00M
Net Income (Profit) i₹3.85M₹867.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CHOKSILASYNGENE
Cash & Equivalents i₹6.12M₹3.67B
Total Current Assets i₹163.21M₹22.87B
Total Current Liabilities i₹238.75M₹13.96B
Long-Term Debt i₹159.63M₹4.09B
Total Shareholders Equity i₹236.05M₹47.27B
Retained Earnings i₹150.56M₹38.82B
Property, Plant & Equipment i₹471.35M₹27.42B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CHOKSILASYNGENE
Operating Cash Flow iN/A₹2.17B
Capital Expenditures iN/A₹-680.00M
Free Cash Flow iN/A₹1.27B
Debt Repayment iN/A₹0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCHOKSILASYNGENE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i8,255420,859
Average Daily Volume (90 Day) i7,354596,172
Shares Outstanding i6.97M401.37M
Float Shares i3.47M175.54M
% Held by Insiders i0.59%0.53%
% Held by Institutions i0.00%0.32%

Dividend Analysis & Yield Comparison: Choksi Laboratories vs Syngene

MetricCHOKSILASYNGENE
Last 12-Month Dividend iN/A₹2.50
Last 12-Month Dividend Yield iN/A0.39%
3-Year Avg Annual Dividend iN/A₹1.25
3-Year Avg Dividend Yield iN/A0.14%
3-Year Total Dividends iN/A₹3.75
Ex-Dividend DateN/AJun 27, 2025